» Articles » PMID: 38783022

Molecular Insights into the Ebola Virus Life Cycle

Overview
Journal Nat Microbiol
Date 2024 May 23
PMID 38783022
Authors
Affiliations
Soon will be listed here.
Abstract

Ebola virus and other orthoebolaviruses cause severe haemorrhagic fevers in humans, with very high case fatality rates. Their non-segmented single-stranded RNA genome encodes only seven structural proteins and a small number of non-structural proteins to facilitate the virus life cycle. The basics of this life cycle are well established, but recent advances have substantially increased our understanding of its molecular details, including the viral and host factors involved. Here we provide a comprehensive overview of our current knowledge of the molecular details of the orthoebolavirus life cycle, with a special focus on proviral host factors. We discuss the multistep entry process, viral RNA synthesis in specialized phase-separated intracellular compartments called inclusion bodies, the expression of viral proteins and ultimately the assembly of new virus particles and their release at the cell surface. In doing so, we integrate recent studies into the increasingly detailed model that has developed for these fundamental aspects of orthoebolavirus biology.

References
1.
Biedenkopf N, Bukreyev A, Chandran K, Di Paola N, Formenty P, Griffiths A . Renaming of genera Ebolavirus and Marburgvirus to Orthoebolavirus and Orthomarburgvirus, respectively, and introduction of binomial species names within family Filoviridae. Arch Virol. 2023; 168(8):220. DOI: 10.1007/s00705-023-05834-2. View

2.
Izudi J, Bajunirwe F . Case fatality rate for Ebola disease, 1976-2022: A meta-analysis of global data. J Infect Public Health. 2023; 17(1):25-34. DOI: 10.1016/j.jiph.2023.10.020. View

3.
Bodmer B, Breithaupt A, Heung M, Brunetti J, Henkel C, Muller-Guhl J . characterization of the novel ebolavirus Bombali virus suggests a low pathogenic potential for humans. Emerg Microbes Infect. 2022; 12(1):2164216. PMC: 9858441. DOI: 10.1080/22221751.2022.2164216. View

4.
Olejnik J, Hume A, Leung D, Amarasinghe G, Basler C, Muhlberger E . Filovirus Strategies to Escape Antiviral Responses. Curr Top Microbiol Immunol. 2017; 411:293-322. PMC: 5973841. DOI: 10.1007/82_2017_13. View

5.
Bodmer B, Gressler J, Schmidt M, Holzerland J, Brandt J, Braun S . Differences in Viral RNA Synthesis but Not Budding or Entry Contribute to the In Vitro Attenuation of Reston Virus Compared to Ebola Virus. Microorganisms. 2020; 8(8). PMC: 7463789. DOI: 10.3390/microorganisms8081215. View